- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|RGB 286638 | RGB286638|
|RGB-286638 is a multi-targeted kinase inhibitor. It inhibits transcriptional-type CDKs (cyclin dependent kinases) such as CDK9, to achieve an anti-multiple myeloma effect which is independent of p53 status , providing a proof of concept which could lead to the development of compounds with activity in p53 deleted multiple myeloma.
A Phase I safety and tolerability study, NCT01168882, was withdrawn from ClinicalTrials.gov (2012), although results of this study have been published..
|CAS Registry No.||784210-88-4|
|GtoPdb PubChem SID||223366077|
|Search Google for chemical match using the InChIKey||XLSYZSRXVVCHLS-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||XLSYZSRXVVCHLS|
|Search UniChem for chemical match using the InChIKey||XLSYZSRXVVCHLS-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||XLSYZSRXVVCHLS|